Mechanisms of accelerated liver fibrosis in HIV-HCV coinfection.
Chrysanthidis T, Loli G, Metallidis S, Germanidis G.
AIDS Rev. 2017 Sep
19;19
Abstract
MAIT-cell frequency and function in blood and liver of HCV mono- and HCV/HIV
co-infected patients with advanced fibrosis.
[The Netherlands{
Beudeker
BJB, van Oord GW, Arends JE,
Liver Int. 2017 Aug 9
Abstract
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the
Swiss HIV Cohort Study.
Béguelin C, Suter A, Bernasconi E, et al
Liver Int. 2017 Jul
25. doi: 10
Abstract
FULL-TEXT ARTICLE
A prognostic model for development of significant liver fibrosis in
HIV-hepatitis C co-infection.
Moqueet N, Kanagaratham C, Gill MJ, et al
PLoS One. 2017 May 3;12(5):e0176282
Paper
Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected
subjects: A Women's interagency HIV study.
Desai SN, Dodge JL, Landay AL, et al
Medicine (Baltimore). 2016
Aug;95(33):e4483
Abstract |
Improving treatment and liver fibrosis outcomes with metformin in
HCV-HIV co-infected and HCV mono-infected patients with insulin
resistance: study protocol for a randomized controlled trial.
Doyle MA, Singer J, Lee T, et al
Trials. 2016 Jul
20;17(1):331.
Abstract
A new 3p25 locus is associated with liver fibrosis progression in
HIV/HCV co-infected patients.
Ulveling D, Le
Clerc S, Cobat A, et al
Hepatology.
2016 Jun 23.
Abstract |
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in
HIV/HCV co-infected patients with absent or minimal fibrosis: implications for
timing of therapy.
Frías M, Rodríguez-Cano D, Cuenca-López F, et al
Pharmacogenomics J. 2016
May 31..
Abstract
FULL-TEXT ARTICLE
High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis
Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen
Truong T, Laureillard D, et al
PLoS One. 2016 May
5;11(5):e0153744.
Paper
Biochemical non-invasive assessment of liver fibrosis cannot
replace biopsy in HIV-HCV coinfected patients.
Kliemann DA, Wolff FH, Tovo CV,
et al
Ann Hepatol. 2015 Jan-2016
Feb;15(1):27-32.
Abstract
Enhanced liver fibrosis marker as a non-invasive predictor of mortality in
HIV/HCV-coinfected women from the women's Interagency HIV study.
Peters MG, Bacchetti P,
Boylan R, et al
AIDS. 2015 Nov 20
Abstract
Liver fibrosis in human immunodeficiency virus/hepatitis C virus
coinfection: Diagnostic methods and clinical impact.
Sagnelli C, Martini S, Pisaturo M, et al
World J Hepatol. 2015
Oct 28;7(24):2510-21
Abstract
FULL-TEXT ARTICLE
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A
Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
Schmid P, Bregenzer A, Huber M,
PLoS One. 2015 Sep
29;10(9):e0138838.
Paper
Progression of liver fibrosis and modern combination antiretroviral therapy
regimens in HIV-hepatitis C co-infected persons.
Brunet L, Moodie EE, Young J, et
al
Clin Infect Dis.
2015 Sep 23.
Abstract
Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients:
Implications for Clinical Practice.
Sacchi P, Cima S, Zuccaro V, et al
AIDS Rev. 2015
Jul-Sep;17(3):159-70.
Abstract
Opioid use and risk of liver fibrosis in HIV/hepatitis C
virus-coinfected patients in Canada.
Brunet L, Moodie E, Cox J, et al
HIV Med.
2015 Jul 3.
Abstract
Fibrosis Regression Explains Differences in Outcome in
HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological
Response.
Casado JL, Esteban MA, Bañón S,
et al
Dig Dis Sci. 2015
Jun 26.
Abstract
FULL-TEXT ARTICLE
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection - The
Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet
Ratio Index.
Rollet-Kurhajec KC, Moodie EE, et al
PLoS One. 2015 Jun
19;10(6):e0129868.
Paper
Delayed liver fibrosis in HTLV-2-infected patients
co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral
therapy.
Abad-Fernández M, Moreno A, Dronda F, et al.
AIDS. 2015 Jan 5.
Abstract
Liver fibrosis, microbial translocation and immune activation
markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P, Cima S, Corbella M, et al
Dig Liver Dis.
2014 Nov 29
Abstract
Liver fibrosis progression despite HCV cure with antiviral therapy in
HIV-HCV-coinfected patients.
Labarga P, Fernandez-Montero JV, de Mendoza C, et al
Antivir Ther. 2014 Nov 5.
Abstract
FULL-TEXT ARTICLE
PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage
and Degree of Portal Hypertension.
Jansen C, Leeming DJ, Mandorfer M,. et a
PLoS One. 2014 Sep
29;9(9):e108544
Paper
Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV
mono-infected patients by transient elastometry.
Mazzocato S, Orsetti E, Gesuita R,
et al
Scand J Infect Dis. 2014
Sep 22:1-6. [
Abstract
FULL-TEXT
ARTICLE
Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as
Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV
Coinfected Patients.
Corchado S, López-Cortés LF, Rivero-Juárez A,
et al
PLoS One. 2014 Jul
11;9(7):e101760.
Paper
Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and
prioritization of new hepatitis C therapies.
Labarga P, Fernández-Montero JV, López M,
et al
Antivir Ther. 2014 Jun 25.
Abstract
Increased incidence of antiretroviral drug discontinuation
among patients with viremic hepatitis C virus coinfection and high
hyaluronic acid, a marker of liver fibrosis.
Grint D, Peters L, Rockstroh JK, et
al
AIDS.
2014 Feb 20;28(4):577-87.
Abstract
Regression of liver fibrosis is progressive after sustained
virological response to HCV therapy in patients with hepatitis C and HIV
coinfection.
Casado JL, Quereda C, Moreno A, Pérez-Elías MJ,
et al
J Viral Hepat. 2013 Dec;20(12):829-37.
Abstract
Liver fibrosis progression in HIV-HCV-coinfected patients
treated with distinct antiretroviral drugs and impact of
peginterferon-ribavirin therapy.
Fernández-Montero JV, Barreiro P, et al
Antivir Ther. 2013 Nov 5..
Abstract
FULL-TEXT ARTICLE
The progression of liver fibrosis in prison inmates
co-infected by HIV and HCV who started on boosted protease inhibitor therapy
Saiz de la Hoya Zamácola P, Alía Alía C,
et al
Rev Esp Sanid Penit.
2013 Oct;15(2):54-62.
Paper
Factors influencing liver fibrosis and necroinflammation in
HIV/HCV coinfection and HCV monoinfection.
Sagnelli C, Uberti-Foppa C,
Pasquale G, et al
Infection.
2013 Jul 10.
Abstract
Prediction of hepatic fibrosis in patients coinfected with human
immunodeficiency virus and hepatitis C virus based on genetic markers.
Fernández-Rodríguez A, Berenguer J, Jiménez-Sousa MA, et alJ
Acquir Immune Defic Syndr. 2013 Jun 21.
Abstract
FULL-TEXT ARTICLE
Predictive Value of Liver Enzymes and Inflammatory Biomarkers for
the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected
Patients.
Charpentier C, Champenois K, Gervais A, et al
PLoS One. 2013;8(3):e59205
Paper
Effect of HIV on Liver Fibrosis among HCV-Infected
African Americans.
Silver D, Karnik G, Osinusi A, Silk R,
et al
Clin Infect Dis. 2013 Feb
1 [
Abstract |
HIV/HCV
Main
Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
